SLGL Stock Analysis: Buy, Sell, or Hold?
SLGL - Sol-Gel Technologies Ltd. Ordinary Shares
$71.26
-2.54 (-3.44%)
▼
5d:
-3.47%
30d:
+4.32%
90d:
+7.64%
BUY
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: May 22, 2026
0d
Get Alerted When SLGL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: SLGL shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: SLGL shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: SLGL is currently trading at $71.26, which is considered fair relative to its 30-day fair value range of $69.24 to $76.55.
Technical Outlook: Technically, SLGL is showing sideways momentum. Immediate support is located at $66.00, while resistance sits at $81.53. Short-term momentum is weak, with the stock down 3.4% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $147.00 (+106.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SLGL is showing sideways momentum. Immediate support is located at $66.00, while resistance sits at $81.53. Short-term momentum is weak, with the stock down 3.4% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $147.00 (+106.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$69.24 -
$76.55
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
69.5%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.4%)
- BULLISH: Trading 106.3% below Wall St target ($147.00)
Trading Range Analysis
30-Day Trading Range
$69.24 -
$76.55
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$66.00
Resistance Level
$81.53
Current Trend
Sideways
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.55
Wall Street Target
$147.00
(+106.3%)
Revenue Growth (YoY)
-89.5%
Earnings Growth (YoY)
487.6%
Profit Margin
-5.7%
Share & Embed Analysis
Last updated: June 24, 2026 6:14 AM ET
Data refreshes hourly during market hours. Next update: 7:14 AM
Data refreshes hourly during market hours. Next update: 7:14 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SLGL showing a specific setup today?
Insider Activity (6 Months)
6
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Opaleye Management Inc.
BUY
100 shares
2026-01-27
Opaleye Management Inc.
BUY
1151 shares
2026-01-23
Opaleye Management Inc.
BUY
2173 shares
2026-01-22
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 65 BUY |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$436 | 54 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 67 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 59 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$58 | 52 HOLD |
